Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MEI Pharma Inc (NASDAQ:MEIP)

1.91
Delayed Data
As of 3:59pm ET
 +0.05 / +2.69%
Today’s Change
1.47
Today|||52-Week Range
8.33
-55.27%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$63.5M

Company Description

MEI Pharma, Inc. is an oncology company, which focuses on the clinical development of novel small molecules for the treatment of cancer. The company currently focuses on the clinical development of two drug candidates, PWT143 and ME-344. MEI Pharma was founded on December 1, 2000 and is headquartered in San Diego, CA.

Contact Information

MEI Pharma, Inc.
11975 El Camino Real
San Diego California 92130-2541
P:(858) 792-6300
Investor Relations:
(858) 369-7199

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Daniel P. GoldPresident, Chief Executive Officer & Director
Thomas M. ZechChief Financial Officer & Secretary
Ofir MorenoVice President-Research & Development
Robert D. MassChief Medical Officer
Wendy J. LevinVP-Clinical Development & Medical Affairs